• Regeneus Ltd HiQCell Joint Registry

    Regeneus publishes updated HiQCell Joint Registry Interim Report

    August 2014: Regeneus have published an updated HiQCell Joint Registry Interim Report, detailing further results from its ethics approved joint registry used to track the safety and effectiveness of HiQCell in the treatment of osteoarthritis.

    Download a copy of the updated
    HiQCell Joint Registry Interim Report »

  • Injection of the HiQCell stem cell therapy

    Regeneus receives ethics approval for collecting stem cells from human donors for first in-man safety trial of its off-the-shelf treatment for OA

    The approval allows RGS to begin manufacturing the cells for its first-in-man clinical trial to assess initial safety and preliminary efficacy in human volunteers with knee OA.

    More »

  • CryoShot - an allogeneic stem cell therapy

    Off-the-shelf stem cell therapy to treat canine and equine osteoarthritis

    CryoShot is an allogeneic cell-based product derived from regenerative cells in adipose tissue including mesenchymal stem cells and adipocytes for the canine and equine markets.

    More »

  • Stem cell therapy specialist at work

    Regeneus validates therapeutic benefits of stem cell secretions platform

    Regeneus completed a successful trial validating the efficacy of the company's adipose (fat) derived stem cell secretion therapy using a well-established mouse model for rheumatoid arthritis.

    More »

Improving quality of life through innovative cellular therapies

Regeneus is excited to announce that over 450 patients have now been commercially treated with our HiQCell® stem cell therapy.

These patients are captured within our Patient Joint Registry which allows us to continue to capture long-term data so that we can learn more of the treatment effects of HiQCell.

More about HiQCell stem cell therapy »

At Regeneus, we focus on improving quality of life through cellular therapies.

We develop and commercialise proprietary technologies for the preparation of autologous point-of-care and off-the-shelf cell therapies for the treatment of musculoskeletal and other inflammatory conditions in humans and animals.

More about Regeneus »

Our Therapies

Human Health

Animal Health

CryoShot is an off-the-shelf stem cell therapy used for the treatment of conditions such as osteoarthritis in dogs and horses. More » about CryoShot